Donidalorsen

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameDonidalorsen
Drug Alias NameIONIS-PKK-LRxISIS-PKKRxIONIS-PKKRxISIS-PKKDAWNZERA +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionKallikreins inhibitors
TargetsKallikreins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Angioedemas, HereditaryMigraine Disorders
Global Approved IndicationsAngioedemas, Hereditary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/08/21
Country/TerritoryBelgiumBulgariaCanada +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncOtsuka Pharmaceutical Netherlands Bv
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Angioedemas, Hereditary
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A